All News
EULAR 2021 - Opening Day
RheumNow has begun covering EULAR 2021, the premier Rheumatology Congress that is usually held in Europe, but has gone virtual in 2021 because of the pandemic. We have several faculty members around the world reporting on the this year's meeting.
Please visit RheumNow.com daily for the latest videos, tweet summaries, news articles and podcasts emanating from EULAR.
Look for our coverage on these and other important topics:
What is your treat to target for lupus patients? #EULAR2021 @rheumnow
k dao KDAO2011 ( View Tweet)
ILD in RA is a killer! @eular_org abst OP0099 Admin day from France claims database. ILD was clinically dx in 2.5% & had 3X mortality. Low prevalence compared to some studies of 6% so maybe worst cases but Impt cause of excess death in RA @RheumNow @eular_org @jeffsparks https://t.co/mPfpPSHxsd
Janet Pope Janetbirdope ( View Tweet)
The post hoc EXCEED analysis showed similar efficacy of SEC and ADA with respect to enthesitis burden. What drug class do you choose as first line therapy for your PsA patients with prominent enthesitis? #EULAR2021 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. Angioni et al characterize PsA clinical remission on a molecular level. c-FOS and CCD50 (YMER) appear to be two key genes. #EULAR2021 poster #POS0409 @RheumNow https://t.co/4lytsgjdzj https://t.co/ySjIXBHTA0
Links:
Dr. Rachel Tate uptoTate ( View Tweet)
Does it matter if you diagnose a symptomatic pt w/ nr-axSpA vs r-axSpA? (2/2) Interestingly there are smaller deltas between ASAS40 results in PBO vs nr-axSpA compared to axSpA vs PBO in MEASURE 2, PREVENT, COAST-V, COAST-X, RAPID, C-axSpAnd. Dr. Deodhar #EULAR2021 @RheumNow https://t.co/V8zlZdGltQ
Dr. Rachel Tate uptoTate ( View Tweet)
"50% of time spent in LLDAS = 50% less damage accrual"- Prof E Morand reviews data on low disease activity state in lupus https://t.co/FU3hPvuyRU
k dao KDAO2011 ( View Tweet)
Prof Van Vollenhoven reveals the Definition of Remission in SLE (DORIS 2021): treating SLE to target #EULAR2021 @rheumnow
👉SLEDAI=0
👉MD global<0.5
👉dsDNA, C3/C4 does not matter
👉prednisone <=5 mg/d, stable meds
👉remission can be met at any point (duration not required https://t.co/TwusJkXR19
k dao KDAO2011 ( View Tweet)
Does it matter if you diagnose a symptomatic patient with nr-axSpA vs radiographic axSpA? (1/2)Dr. Deodhar discusses differences in tx withdrawal/dose reduction(PBO) shown in RE-EMBARK, ABILITY-3, C-OPTIMISE. #EULAR2021 @RheumNow https://t.co/wVYsPYFLAi
Dr. Rachel Tate uptoTate ( View Tweet)
MUC5B variant gene in 5634 RA pts had 2X ⬆️ risk of RA ILD - same gene as in IPF. Clinical relevance is unknown but could it result in a novel Rx pathway? ? Effect of sex & smoking @RheumNow @eular_org abst OP0007 #EULAR2021 https://t.co/8XpKjPFfUX
Janet Pope Janetbirdope ( View Tweet)
To clot or NOT? Real world data usually show no ⬆️ VTE in RA with #Jaki compares to other advanced therapies. Diff from high CV risk pts in Oral Surveillance where Tofacitinib had higher VTE vs TNFi @AbbVie symposium @eular_org #EULAR2021 @RheumNow Hard to reconcile diff risk. https://t.co/AWY2zZPSIb
Janet Pope Janetbirdope ( View Tweet)
Dr. Deodhar reviews ASAS imaging/clinical classification and defines nrAxSpA at #EULAR2021 @RheumNow https://t.co/OdlQvGyNfY
Dr. Rachel Tate uptoTate ( View Tweet)
Introducing EULAR's new name: 'European Alliance of Associations for Rheumatology' highlighting the importance of collaboration in the scientific community and bringing the patient’s voice across all bodies of work #EULAR2021 @rheumnow
k dao KDAO2011 ( View Tweet)
Andrew Ostor @AbbVie symposium @eular_org presented HZ vaccines are safe in RA pts with #JAKi but with Recombinant HZ vaccine humeral response - 75% in RA pts in JAKi vs 100% controls. So should we hold JAKi with Shringix & if so for 1 or 2 wks? #EULAR2021 @RheumNow https://t.co/wVOFMa9fLm
Janet Pope Janetbirdope ( View Tweet)
Lifetime risk of HZ is 30%! ⬆️ in pts with immune diseases or immunesuppression. All #JAKI ⬆️ risk maybe doubling but NNH & NNT give context. UPA Rx in active RA -20 more pts in remission vs 1 excess HZ if comparing UPA to ADA in RA @RheumNow #EULAR2021 AbbVie symposium https://t.co/14i0IsIpzs
Janet Pope Janetbirdope ( View Tweet)
Do you think JAKi cause VTE? @eular_org @RheumNow #EULAR2021
Janet Pope Janetbirdope ( View Tweet)
Do you think #JAKI ⬆️ #MACE cardiovascular events vs TNFi? @eular_org @RheumNow #EULAR2021
Janet Pope Janetbirdope ( View Tweet)
"We can be soloist or collaborators." - Mark Pollock, keynote speaker #EULAR2021, inspires people to build resilience and collaborate w/others to achieve more than they thought possible. He was the 1st blind person to race to the South Pole @RheumNow https://t.co/qYpBr1I9US
k dao KDAO2011 ( View Tweet)
New download available!
Difficult RA Defined
https://t.co/6WGMEiwiUk https://t.co/VTCm4cuyRe
Links:
Dr. John Cush RheumNow ( View Tweet)
Novartis announced that Cosentyx (secukinumab) has received FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis #EULAR2021 https://t.co/JlkmjLwqQ8
Links:
Dr. John Cush RheumNow ( View Tweet)